Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense

Activity by year

2020202120222023202420252026

Contract

Jul 16, 2020CONTRACTKeene, N.H., United States$20.0M
Smiths Medical receives $20M federal funding for syringe production expansion
Smiths Medical partnered with BARDA and the DoD to expand capacity at its Keene, N.H. facility for hypodermic needle and syringe production. BARDA will invest $20 million into a $38 million capital expansion project, and Smiths Medical received an order for 78.6 million syringe and needle units.
Smiths Medical Biomedical Advanced Research and Development Authority customer Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense customer #Medical Devices medicalbuyer.co.in nhbr.com

Suppliers

Loading…

Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense: plants, expansions, contracts and acquisitions · Endata